Eliana Clark

Insider Reports History

Location
Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eliana Clark:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Technical Officer Common Stock 93,864 $1,293,445 $13.78 02 Mar 2026 Direct
Intellia Therapeutics, Inc. EVP, Chief Technical Officer Stock Option (right to buy) 10,505 01 Mar 2026 Direct

Insider Reports Filed by Eliana Clark

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 01 Mar 2026 3 -$8,364 4 EVP, Chief Technical Officer 03 Mar 2026, 16:16
NTLA Intellia Therapeutics, Inc. 05 Jan 2026 1 -$87,633 4 EVP, Chief Technical Officer 07 Jan 2026, 16:03
NTLA Intellia Therapeutics, Inc. 01 Jul 2025 1 -$10,036 4 EVP, Chief Technical Officer 03 Jul 2025, 16:11
NTLA Intellia Therapeutics, Inc. 01 Mar 2025 3 -$6,104 4 EVP, Chief Technical Officer 04 Mar 2025, 16:43
NTLA Intellia Therapeutics, Inc. 02 Jan 2025 2 -$97,089 4 EVP, Chief Technical Officer 06 Jan 2025, 16:16
NTLA Intellia Therapeutics, Inc. 01 Jul 2024 1 -$9,287 4 EVP, Chief Technical Officer 03 Jul 2024, 13:15
NTLA Intellia Therapeutics, Inc. 01 Mar 2024 3 -$19,959 4 EVP, Chief Technical Officer 05 Mar 2024, 16:10
NTLA Intellia Therapeutics, Inc. 03 Jan 2024 2 -$135,954 4 EVP, Chief Technical Officer 05 Jan 2024, 16:44
NTLA Intellia Therapeutics, Inc. 03 Jul 2023 1 -$14,584 4 EVP, Chief Technical Officer 06 Jul 2023, 15:34
NTLA Intellia Therapeutics, Inc. 20 Jun 2023 3 -$163,650 4 EVP, Chief Technical Officer 22 Jun 2023, 17:52
NTLA Intellia Therapeutics, Inc. 01 Mar 2023 3 $0 4 EVP, Chief Technical Officer 03 Mar 2023, 16:12
NTLA Intellia Therapeutics, Inc. 01 Jul 2022 3 -$76,357 4 EVP, Chief Technical Officer 06 Jan 2023, 16:21
NTLA Intellia Therapeutics, Inc. 01 Mar 2022 2 $0 4 EVP, Chief Technical Officer 07 Mar 2022, 18:19
NTLA Intellia Therapeutics, Inc. 23 Feb 2022 0 $0 3 EVP, Chief Technical Officer 07 Mar 2022, 18:15